A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia | Zendy

Adrian Tempescul | Zendy; Johanna Feuerbach | Zendy; JeanChristophe Ianotto | Zendy; Florence Dalbiès | Zendy; Véronique Marion | Zendy; MarieJosée Le Bris | Zendy; Marc De Braekeleer | Zendy; Christian Berthou | Zendy

Open Access

A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia

Author(s) -

Adrian Tempescul,

Johanna Feuerbach,

JeanChristophe Ianotto,

Florence Dalbiès,

Véronique Marion,

MarieJosée Le Bris,

Marc De Braekeleer,

Christian Berthou

Publication year - 2008

Publication title -

annals of hematology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.079

H-Index - 80

eISSN - 1432-0584

pISSN - 0939-5555

DOI - 10.1007/s00277-008-0541-5

Subject(s) - prolymphocytic leukemia , fludarabine , chromosomal translocation , cd5 , gene rearrangement , biology , rituximab , mitoxantrone , hematology , bone marrow , cancer research , pathology , medicine , leukemia , immunology , chronic lymphocytic leukemia , lymphoma , chemotherapy , gene , cyclophosphamide , genetics

International audienc

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog